Mesothelin expression and survival outcomes in triple-receptor negative breast cancer.

被引：0
|
作者：
Parinyanitikul, Napa
Blumenschein, George R.
Wu, Yun
Lei, Xiudong
Gregor, Mariana Chavez-Mac
Smart, Melody L.
Gonzalez-Angulo, Ana M.
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Breast Med Oncol Dept, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e12002
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Mesothelin Expression and Survival Outcomes in Triple Receptor Negative Breast Cancer
    Parinyanitikul, Napa
    Blumenschein, George R.
    Wu, Yun
    Lei, Xiudong
    Chavez-MacGregor, Mariana
    Smart, Melody
    Gonzalez-Angulo, Ana Maria
    [J]. CLINICAL BREAST CANCER, 2013, 13 (05) : 378 - 384
  • [2] ANDROGEN RECEPTOR EXPRESSION IN TRIPLE NEGATIVE BREAST CANCER.
    Govindalayathil, P. Chelakkot
    Vijayan N, S.
    Ravind, R.
    Sheejamol, V. S.
    Keechilat, P.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 : 12 - 13
  • [3] Survival outcomes across ethnicities in triple-negative breast cancer.
    Rushton, Moira Katherine
    Zhang, Tinghua
    Song, Xinni
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] Androgen receptor expression and survival in triple negative breast cancer
    Moyano, L.
    Soto, J. L.
    Garmendia, M. L.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S32 - S32
  • [5] The Unmet Need for Effective Treatment of Triple-Receptor Negative Breast Cancer
    Gradishar, William J.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2014, 12 (08) : 6 - 10
  • [6] Association between mesothelin expression and survival outcomes in patients with triple-negative breast cancer: A protocol for a systematic review
    Wang M.
    Li A.
    Sun G.
    Mbuagbaw L.
    Reid S.
    Lovrics P.J.
    Thabane L.
    [J]. Systematic Reviews, 5 (1)
  • [7] Is breast conservation therapy a viable option for patients with triple-receptor negative breast cancer?
    Parker, Catherine C.
    Ampil, Fred
    Burton, Gary
    Li, Benjamin D. L.
    Chu, Quyen D.
    [J]. SURGERY, 2010, 148 (02) : 386 - 391
  • [8] ZMIZ2 promotes the development of triple-receptor negative breast cancer
    Xiaopan Zou
    Yan Liu
    Jun Di
    Wei Wei
    Nobumoto Watanabe
    Jiang Li
    Xiaomeng Li
    [J]. Cancer Cell International, 22
  • [9] ZMIZ2 promotes the development of triple-receptor negative breast cancer
    Zou, Xiaopan
    Liu, Yan
    Di, Jun
    Wei, Wei
    Watanabe, Nobumoto
    Li, Jiang
    Li, Xiaomeng
    [J]. CANCER CELL INTERNATIONAL, 2022, 22 (01)
  • [10] The role of histology on survival of triple negative breast cancer.
    Parise, Carol
    Caggiano, Vincent
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
12345